JOURNAL OF DIABETES AND ITS COMPLICATIONS, cilt.29, sa.4, ss.550-555, 2015 (SCI İndekslerine Giren Dergi)
Background: Serum fibroblast growth factor 23 (FGF-23) and fetuin-A are established predictors of morbidity and mortality due to cardiovascular disease. The objective of the present study is to evaluate the relationship between coronary artery disease (CAD) and serum concentrations of FGF-23 and fetuin-A.